SEC13

Protein SEC13 homolog · P55735 · SEC13 on Sugi Atlas →

0 patent compounds predicted against SEC13, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SEC13 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3COMPLETED
TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options PHASE3COMPLETED
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops PHASE2UNKNOWN
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Association Between Intakes of Protein, Calcium and Milk With Gene Expression and Linear Growth of School Aged Children nanCOMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Study of Constitutional Platelet Disease nanUNKNOWN
SLC13A5 Deficiency Natural History Study - Remote Only nanENROLLING_BY_INVITATION
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Correlation Between PT and INR to Factor 7 nanUNKNOWN
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions nanRECRUITING
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI) nanRECRUITING
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SEC13 binder may also engage these)

ProteinNameSimilarity
Q5XFW8 1.000 Q5XFW8 →
Q9D1M0 1.000 Q9D1M0 →
Q3ZCC9 1.000 Q3ZCC9 →
A5DHD9 0.997 A5DHD9 →
Q5AEF2 0.996 Q5AEF2 →
Q6BZX5 0.995 Q6BZX5 →
O64740 0.994 O64740 →
A5DXE2 0.994 A5DXE2 →
Q6FNV4 0.993 Q6FNV4 →
Q6CSZ5 0.992 Q6CSZ5 →
Q0CHM0 0.991 Q0CHM0 →
Q04491 0.990 Q04491 →
P53024 0.990 P53024 →
A4REK3 0.990 A4REK3 →
G0SA60 0.989 G0SA60 →
Q5B563 0.989 Q5B563 →
Q9SRI1 0.988 Q9SRI1 →
Q54DS8 0.988 Q54DS8 →
Q7RZF5 0.988 Q7RZF5 →
Q75BS2 0.987 Q75BS2 →
Q2GSM6 0.987 Q2GSM6 →
Q1DZQ0 0.986 Q1DZQ0 →
O94319 0.986 O94319 →
Q4PCB8 0.986 Q4PCB8 →
A1CGS0 0.985 A1CGS0 →
Q6BIR1 0.985 Q6BIR1 →
A2QHM1 0.984 A2QHM1 →
Q0UNA9 0.984 Q0UNA9 →
Q2UG43 0.984 Q2UG43 →
Q7K4B3 0.983 Q7K4B3 →